Endra Life Sciences INC. (NDRA) — S-1/A Filings

All S-1/A filings from Endra Life Sciences INC.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (4)

ENDRA Files S-1/A for Continuous Offering, Signaling Capital Raise — Jul 25, 2025 Risk: high
ENDRA Life Sciences Inc. (NDRA) filed an S-1/A on July 25, 2025, for a delayed or continuous offering of securities, indicating a capital raise strategy rather
ENDRA Life Sciences Amends S-1, Signals Capital Raise Intent — Jul 16, 2025 Risk: medium
ENDRA Life Sciences Inc. (NDRA) filed an S-1/A on July 16, 2025, for a continuous offering of securities under Rule 415, indicating a strategic move to raise ca
ENDRA Life Sciences Files S-1/A Amendment — May 31, 2024 Risk: medium
ENDRA Life Sciences Inc. filed an S-1/A amendment on May 31, 2024, related to its registration statement (No. 333-278842). The company, incorporated in Delaware
ENDRA Life Sciences Files S-1/A Amendment — May 10, 2024 Risk:
ENDRA Life Sciences Inc. (NDRA) filed a Amended IPO Registration (S-1/A) with the SEC on May 10, 2024. ENDRA Life Sciences Inc. filed an S-1/A amendment on May

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX